Biocon's Insulin Manufacturing Facility in Malaysia Completes USFDA inspection with three observations Medical Dialogues Bureau24 Feb 2020 6:41 AM GMTMalaysia:Drug major Biocon recently informed about the USFDA inspection at its Insulin Manufacturing Facility in Malaysia, and that the agency issued...